GB

Gayathri Bhavikatti

Active Director Director DIN 02172394
DIN 02172394 First appointment Jul 2008 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2008
Shareholding value •••• Premium profile

About Gayathri Bhavikatti

Data last updated:

Gayathri Bhavikatti is a Director at Imed Pharmaceuticals (India) Private Limited (since 2008). The company operates in Healthcare. Imed Pharmaceuticals (India) Private Limited reported revenue of ₹7.24 Cr (FY 2015).

DIN 02172394
Primary Designation Director
Industry Healthcare
First Appointment 15 Jul 2008
Oldest Company Age 18 yrs
Largest company Imed Pharmaceuticals (India) Private Limited · ₹7.24 Cr (FY 2015)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jul 20082008₹7.24 Cr (FY 2015)Active

Board colleagues of Gayathri Bhavikatti

Directorship timeline

Open interactive timeline →
Imed Pharmaceuticals (India) Private Limited
Premium access

Shareholding and investment profile for Gayathri Bhavikatti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gayathri Bhavikatti

Gayathri Bhavikatti currently holds 1 directorship: Imed Pharmaceuticals (India) Private Limited (Director, since 15 Jul 2008, revenue ₹7.24 Cr (FY 2015)).

Gayathri Bhavikatti was first appointed on 15 Jul 2008 as Director at Imed Pharmaceuticals (India) Private Limited.

The current boards of Gayathri Bhavikatti's companies include Narasappa Swamy Bhavikatti (Imed Pharmaceuticals (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available